Comparative Pharmacology
Head-to-head clinical analysis: MULTIHANCE MULTIPACK versus OPTIMARK IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: MULTIHANCE MULTIPACK versus OPTIMARK IN PLASTIC CONTAINER.
MULTIHANCE MULTIPACK vs OPTIMARK IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Gadobenate dimeglumine is a paramagnetic contrast agent that enhances magnetic resonance imaging by increasing the relaxation rate of water protons in tissues where it accumulates. The gadolinium ion (Gd3+) shortens T1 and T2 relaxation times, leading to increased signal intensity on T1-weighted images.
Gadolinium-based paramagnetic contrast agent. The gadolinium ion (Gd3+) has seven unpaired electrons and a high magnetic moment, which enhances the relaxation rates of surrounding water protons in tissues, increasing signal intensity on T1-weighted magnetic resonance imaging (MRI) scans.
0.1 mmol/kg body weight (0.2 mL/kg) intravenous bolus injection; maximum single dose 0.3 mmol/kg (0.6 mL/kg)
0.2 mL/kg (0.1 mmol/kg) IV bolus; may repeat once within 30 minutes for total dose of 0.4 mL/kg (0.2 mmol/kg) if needed for contrast-enhanced MRI.
None Documented
None Documented
Terminal elimination half-life: 1.5–2.2 hours in patients with normal renal function; prolonged (up to 30 hours) in severe renal impairment (eGFR <30 mL/min/1.73m²)
Terminal elimination half-life is approximately 2 hours in patients with normal renal function. In patients with severe renal impairment (GFR < 30 mL/min), half-life may be prolonged up to 30 hours.
Renal excretion: 95% unchanged drug via glomerular filtration; biliary/fecal: <0.1%
Primarily renal excretion via glomerular filtration; >90% of administered dose eliminated unchanged in urine within 24 hours. Less than 1% eliminated in feces.
Category C
Category C
MRI Contrast Agent
MRI Contrast Agent